U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352566) titled 'Utilization of a Microdevice for Psoriasis and Atopic Dermatitis' on Nov. 17, 2025.
Brief Summary: This study is being done to test a microdevice, which is a small device designed to test drugs directly on skin conditions like atopic dermatitis (eczema) and psoriasis.
The small device, about the size of a grain of rice, has up to 20 tiny reservoirs that hold medications that are approved by the Food and Drug Administration (FDA) for atopic dermatitis and psoriasis. Very small amounts of these medications will be released into the skin (at levels in your body much lower than are typically used). In this study, the device will be tes...